Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Active Sponsors

  • Intermountain Health Care, Inc.1
  • University of Oxford1

Top Investigators

Related Conditions

  • Respiratory Distress Syndrome2
  • Respiratory Insufficiency2
  • Respiratory Distress Syndrome Acute1
  • Severe Acute Respiratory Syndrome1
  • Ards1

Activity Timeline